Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Protagonist Therapeutics Inc (NASDAQ: PTGX) closed at $45.92 up 2.57% from its previous closing price of $44.77. In other words, the price has increased by $2.57 from its previous closing price. On the day, 0.65 million shares were traded. PTGX stock price reached its highest trading level at $46.54 during the session, while it also had its lowest trading level at $45.05.
Ratios:
For a deeper understanding of Protagonist Therapeutics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.80 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.72. For the most recent quarter (mrq), Quick Ratio is recorded 13.73 and its Current Ratio is at 13.73. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on September 09, 2024, initiated with a Buy rating and assigned the stock a target price of $60.
On October 30, 2023, CapitalOne started tracking the stock assigning a Overweight rating and target price of $32.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 11 ’24 when Ali Asif sold 14,203 shares for $44.49 per share. The transaction valued at 631,872 led to the insider holds 34,960 shares of the business.
Waddill William D. sold 8,000 shares of PTGX for $360,000 on Sep 10 ’24. The Director now owns 12,000 shares after completing the transaction at $45.00 per share. On Sep 11 ’24, another insider, Ali Asif, who serves as the Officer of the company, bought 14,203 shares for $44.49 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTGX now has a Market Capitalization of 2704899072 and an Enterprise Value of 2151872512. As of this moment, Protagonist’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.48. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.48 while its Price-to-Book (P/B) ratio in mrq is 4.98. Its current Enterprise Value per Revenue stands at 6.743 whereas that against EBITDA is 14.045.
Stock Price History:
Over the past 52 weeks, PTGX has reached a high of $48.00, while it has fallen to a 52-week low of $13.72. The 50-Day Moving Average of the stock is 14.11%, while the 200-Day Moving Average is calculated to be 49.47%.
Shares Statistics:
For the past three months, PTGX has traded an average of 945.00K shares per day and 632160 over the past ten days. A total of 57.71M shares are outstanding, with a floating share count of 55.65M. Insiders hold about 5.53% of the company’s shares, while institutions hold 96.75% stake in the company. Shares short for PTGX as of 1724976000 were 3278065 with a Short Ratio of 3.47, compared to 1722384000 on 2903461. Therefore, it implies a Short% of Shares Outstanding of 3278065 and a Short% of Float of 5.6399997.
